JUBLPHARMANSEJubilant Pharmova Limited· Pharmaceuticals & BiotechnologyHighPositive
Announced Wed, 11 Jun, 2025 · 11:53 IST

Jubilant Pharmova Limited has informed the Exchange about General Updates - Receipt of rectification order from the Income tax department

JUBLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.2%Reaction day
₹1147.70
prior close
₹1155.40
announcement price
In-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.1%-0.1% vs market
Pharmaceuticals peers, median of 150sector+0.5%-0.7% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Smallcap 250 and 0.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.0
10m
+0.0
15m
-0.1
30m
+0.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.2-0.1-0.1+0.5-0.7
Next day
-2.3-1.5-0.8+0.1-2.4
2d
-4.8-1.9-2.9-0.0-4.8
3d
-1.7-1.4-0.3-0.0-1.7
4d
-2.4-2.1-0.3-1.2-1.2
5d
-1.8-2.3+0.5-2.2+0.4
1w
-3.5-3.6+0.0-3.3-0.2
15d
+4.6+0.8+3.7-1.3+5.9
1m
+0.8+0.6+0.2-0.9+1.7
2m
-4.2-5.3+1.1-3.8-0.4
3m
-2.0-2.6+0.6-2.9+0.9
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Jubilant Pharmova has received a rectification order from the Income Tax department dated May 8, 2025, fully deleting a prior tax demand of Rs. 35.90 crores for Assessment Year 2018-19. The company had filed a rectification application against the demand, and the order received on June 10, 2025, cancels the demand entirely. The company has clarified that a separate appeal on merit grounds is still being pursued before CIT(A), so other tax matters remain under review. No penalty, settlement, or financial impact details have been disclosed in this update.

Likely market impact

Positive for shareholders as the full deletion of the Rs. 35.90 crore tax demand removes a potential liability; however, the ongoing merit-based appeal means tax-related uncertainty has not been fully resolved.